Mitochondria transfer in glioblastoma

Area of Science:

• Neuro-oncology
• Cancer Metabolism
• Cellular Biology

Background:

• Glioblastoma (GBM) exhibits aggressive behavior, metabolic adaptability, cellular heterogeneity, and therapy resistance.
• Horizontal mitochondrial transfer (HMT) between GBM cells and the microenvironment, including astrocytes, is a newly identified factor contributing to tumor progression.
• Mitochondrial exchange influences GBM's metabolic reprogramming and resistance to treatments.

Purpose of the Study:

• To review current knowledge on mitochondrial exchange in glioblastoma.
• To explore the mechanisms of HMT, including tunneling nanotubes (TNTs), tumor microtubes (TMs), and extracellular vesicles (EVs).
• To examine the functional consequences of HMT on GBM, such as enhanced oxidative phosphorylation (OXPHOS), tumorigenicity, and therapeutic responses.

Main Methods:

• Literature review of recent research on mitochondrial transfer in GBM.
• Analysis of studies investigating HMT mechanisms (TNTs, TMs, EVs).
• Synthesis of findings on the functional impact of HMT on GBM cell metabolism and behavior.

Main Results:

• HMT occurs in GBM via TNTs, TMs, and potentially EVs, facilitating intercellular communication.
• Mitochondrial transfer enhances GBM cells' oxidative phosphorylation (OXPHOS) capacity.
• HMT contributes to increased GBM tumorigenicity and altered responses to therapies.

Conclusions:

• Mitochondrial exchange is a significant factor in glioblastoma progression and therapy resistance.
• Further research into the molecular mechanisms and context-specific roles of HMT is crucial.
• Targeting HMT presents a potential avenue for novel glioblastoma therapeutic strategies.